About SonoVol
SonoVol is a company based in Durham (United States) founded in 2012 was acquired by PerkinElmer in February 2022. SonoVol offers products and services including Vega automated ultrasound system and VesselVue microbubble contrast agents. SonoVol operates in a competitive market with competitors including SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
- Headquarter Durham, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sonovol.com
- Social LinkedIn X
- Acquired by PerkinElmer (Feb 2022)
- Legal Name Sonovol, Inc.
- Latest Funding Round$250K (USD), Debt – Conventional
Feb 2022
- InvestorsHHS
& 2 more
- Acquired byPerkinElmer
(Feb 2022)
Products & Services of SonoVol
SonoVol offers a comprehensive portfolio of products and services, including Vega automated ultrasound system and VesselVue microbubble contrast agents.
Automated system for fast and reliable disease research imaging.
Agents enhancing ultrasound for noninvasive research applications.
Funding Insights of SonoVol
- Total Rounds 10
- Last Round Debt – Conventional — $250,000
- First Round $250,000
(Jan 2014)
- Investors Count 2
All 10 funding rounds of SonoVol with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $250,000 | Debt – Conventional | – | – | |
| Sep 2020 | $298,892 | Grant | – | – | |
| Sep 2019 | $2.3M | Grant | – | – | |
| Jul 2019 | $243,977 | Grant | – | – | |
| Sep 2017 | $1.88M | Grant | – | – | |
| Aug 2017 | $2.2M | Grant | – | – | |
| Sep 2016 | $1.24M | Grant | – | – | |
| Sep 2015 | $897,890 | Grant | – | – | |
| Apr 2015 | $2.23M | Grant | – | – | |
| Jan 2014 | $250,000 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in SonoVol
SonoVol has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, PerkinElmer and NCBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are incubated and funded in North Carolina. | 1984 | ncbiotech.org | Durham, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Medical instruments and supplies are manufactured and provided for healthcare. | 1931 | perkinelmer.com | Waltham, United States |
Investor details for SonoVol
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SonoVol
4 dated milestones of SonoVol across 10 years, from founding to its latest funding, stage changes and deals.
- Founded SonoVol is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Debt – Conventional, of $250K.
- Exit Acquired by PerkinElmer.
Competitors of SonoVol
SonoVol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| realviewimaging.com | 2008 | Yokneam Illit, Israel | $25M | – | 3D holographic display solutions for medical imaging are provided. | |
| lepumedical.com | 1999 | Beijing, China | – | – | Interventional cardiology devices are developed and marketed globally. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | – | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. |
Detailed competitors of SonoVol
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sonovol
Complete news archive for SonoVol
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to SonoVol
10 companies that operate in the same segment as SonoVol (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SonoVol
SonoVol was founded in 2012 and raised its 1st funding round 2 years after it was founded.
SonoVol is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
SonoVol, a spinout of the University of North Carolina is developing an ultrasonic device for tissue and vasculature imaging in preclinical setting (for rodents). The company offers fully-automated benchtop ultrasound platform, named as Vega, which is a preclinical high throughput imaging platform based on a proprietary technology, Acoustic Angiography. The Acoustic Angiography is based on a contrast-enhanced imaging using microbubbles to noninvasively quantify blood vessels. The company is also developing whole body 3D ultrasound platform for animal testings.
SonoVol's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
SonoVol offers Vega automated ultrasound system and VesselVue microbubble contrast agents.
SonoVol has 3 investors. Key investors include HHS, PerkinElmer, and NCBiotech.
SonoVol operates through Sonovol, Inc..
Yes. SonoVol was acquired by PerkinElmer in February 2022.